Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

‘Tis the season to have your own pharma-themed film festival

Posted on December 23rd, 2019 by

Pharma R&D

The warmest family celebration of the year is almost here! All my friends and colleagues around me have started thinking about the best ways to spend this year’s family gathering. Well, if you are like me—a geeky introvert who enjoys time alone—nothing goes better with family parties and eating huge amounts of food than relaxing on the couch and binge-watching movies and TV shows.

(more…)

What were the most important lessons in Life Sciences in 2019?

Posted on December 20th, 2019 by

Pharma R&D

As 2019 comes to a close, we asked members of Elsevier’s Life Sciences team:

What were the biggest lessons or most noteworthy developments in the Life Sciences industry this year?

(more…)

New studies question what we thought we knew about aspirin

Posted on December 17th, 2019 by

Chemistry

For decades, aspirin (acetylsalicylic acid) has been viewed as something of a wonder drug. A staple in most households, people have turned to it for everything from headache relief to heart attack prevention. However, recent studies have raised some serious questions about the benefits of regular aspirin usage.

(more…)

The Hive is now open for 2020 applications

Posted on December 16th, 2019 by

Pharma R&D

It’s been three years since Elsevier launched The Hive, the innovation initiative for biotech and pharmaceutical start-ups committed to promoting collaboration and inspiration across pharma and the life sciences industry. Now it’s time once again for us to welcome new applicants!

(more…)

New Report on Melanoma Research: 3 Key Findings

Posted on December 13th, 2019 by

Pharma R&D

The current state of melanoma research: insight & analytics, a new report released by Elsevier’s Life Sciences Professional Services, examines the landscape of melanoma R&D and reveals some very interesting findings.

(more…)

Healthy China initiative emphasizes prevention

Posted on December 12th, 2019 by

Pharma R&D

China has made huge strides in its national health since the 1950s when life expectancy was less than 45 years (today, it’s 76-79 years). I was born there in the 1980s and grew up through the beginning phase of economic reform and opening up to the world. The hospital infrastructure and quality of services has gotten much better, and there has been a growth in community healthcare providers and pharmacies. My parents and their generation say the entire healthcare system has improved tremendously. Government, universities and corporations have also been giving a great deal of attention to this area, especially with big data and AI trending.

(more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 70


About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.